Year |
Citation |
Score |
2023 |
Paterson S, Vallatos A, Rodgers J, Holmes WM. Application of diffusion weighted multiple boli ASL to a murine model of human African trypanosomiasis. Scientific Reports. 13: 8684. PMID 37248398 DOI: 10.1038/s41598-023-34665-z |
0.655 |
|
2022 |
Paterson S, Holmes WM, Rodgers J. Serial magnetic resonance imaging of splenomegaly in the Trypanosoma brucei infected mouse. Plos Neglected Tropical Diseases. 16: e0010962. PMID 36477669 DOI: 10.1371/journal.pntd.0010962 |
0.638 |
|
2021 |
Montague P, Bradley B, Rodgers J, Kennedy PGE. Microarray profiling predicts early neurological and immune phenotypic traits in advance of CNS disease during disease progression in Trypanosoma. b. brucei infected CD1 mouse brains. Plos Neglected Tropical Diseases. 15: e0009892. PMID 34762691 DOI: 10.1371/journal.pntd.0009892 |
0.375 |
|
2020 |
Gummery L, Jallow S, Raftery AG, Bennet E, Rodgers J, Sutton DGM. Comparison of loop-mediated isothermal amplification (LAMP) and PCR for the diagnosis of infection with Trypanosoma brucei ssp. in equids in The Gambia. Plos One. 15: e0237187. PMID 32833981 DOI: 10.1371/Journal.Pone.0237187 |
0.413 |
|
2019 |
Rodgers J, Steiner I, Kennedy PGE. Generation of neuroinflammation in human African trypanosomiasis. Neurology(R) Neuroimmunology & Neuroinflammation. 6. PMID 31467039 DOI: 10.1212/Nxi.0000000000000610 |
0.537 |
|
2019 |
Kennedy PGE, Rodgers J. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis. Frontiers in Immunology. 10: 39. PMID 30740102 DOI: 10.3389/Fimmu.2019.00039 |
0.483 |
|
2017 |
Laperchia C, Tesoriero C, Seke-Etet PF, La Verde V, Colavito V, Grassi-Zucconi G, Rodgers J, Montague P, Kennedy PGE, Bentivoglio M. Expression of interferon-inducible chemokines and sleep/wake changes during early encephalitis in experimental African trypanosomiasis. Plos Neglected Tropical Diseases. 11: e0005854. PMID 28821016 DOI: 10.1371/Journal.Pntd.0005854 |
0.353 |
|
2017 |
Rodgers J, Bradley B, Kennedy PGE. Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis. Methods (San Diego, Calif.). PMID 28636879 DOI: 10.1016/J.Ymeth.2017.06.015 |
0.561 |
|
2016 |
Laperchia C, Palomba M, Seke Etet PF, Rodgers J, Bradley B, Montague P, Grassi-Zucconi G, Kennedy PG, Bentivoglio M. Trypanosoma brucei Invasion and T-cell Infiltration of the Brain Parenchyma in Experimental Sleeping Sickness: Timing and Correlation with Functional Changes. Plos Neglected Tropical Diseases. 10: e0005242. PMID 28002454 DOI: 10.1371/Journal.Pntd.0005242 |
0.392 |
|
2015 |
Rodgers J, Bradley B, Kennedy PG, Sternberg JM. Central Nervous System Parasitosis and Neuroinflammation Ameliorated by Systemic IL-10 Administration in Trypanosoma brucei-Infected Mice. Plos Neglected Tropical Diseases. 9: e0004201. PMID 26505761 DOI: 10.1371/Journal.Pntd.0004201 |
0.418 |
|
2015 |
Coles JA, Myburgh E, Ritchie R, Hamilton A, Rodgers J, Mottram JC, Barrett MP, Brewer JM. Intravital imaging of a massive lymphocyte response in the cortical dura of mice after peripheral infection by trypanosomes. Plos Neglected Tropical Diseases. 9: e0003714. PMID 25881126 DOI: 10.1371/Journal.Pntd.0003714 |
0.418 |
|
2015 |
Burrell-Saward H, Rodgers J, Bradley B, Croft SL, Ward TH. A sensitive and reproducible in vivo imaging mouse model for evaluation of drugs against late-stage human African trypanosomiasis. The Journal of Antimicrobial Chemotherapy. 70: 510-7. PMID 25298516 DOI: 10.1093/Jac/Dku393 |
0.384 |
|
2013 |
Myburgh E, Coles JA, Ritchie R, Kennedy PG, McLatchie AP, Rodgers J, Taylor MC, Barrett MP, Brewer JM, Mottram JC. In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis. Plos Neglected Tropical Diseases. 7: e2384. PMID 23991236 DOI: 10.1371/Journal.Pntd.0002384 |
0.51 |
|
2013 |
MacLean L, Myburgh E, Rodgers J, Price HP. Imaging African trypanosomes. Parasite Immunology. 35: 283-94. PMID 23790101 DOI: 10.1111/Pim.12046 |
0.445 |
|
2012 |
Sutton DGM, Morrison LJ, Pollock PJ, Hahn C, Johnston PE, Sharpe S, Rodgers J, Murray M. Trypanosoma brucei central nervous system infection in working equidae in West Africa: an emerging disease Journal of Equine Veterinary Science. 32. DOI: 10.1016/J.Jevs.2012.08.171 |
0.446 |
|
2011 |
Rodgers J, Jones A, Gibaud S, Bradley B, McCabe C, Barrett MP, Gettinby G, Kennedy PG. Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis. Plos Neglected Tropical Diseases. 5: e1308. PMID 21909447 DOI: 10.1371/Journal.Pntd.0001308 |
0.518 |
|
2011 |
Rodgers J, McCabe C, Gettinby G, Bradley B, Condon B, Kennedy PG. Magnetic resonance imaging to assess blood-brain barrier damage in murine trypanosomiasis. The American Journal of Tropical Medicine and Hygiene. 84: 344-50. PMID 21292912 DOI: 10.4269/Ajtmh.2011.10-0487 |
0.47 |
|
2011 |
Jeganathan S, Sanderson L, Dogruel M, Rodgers J, Croft S, Thomas SA. The distribution of nifurtimox across the healthy and trypanosome-infected murine blood-brain and blood-cerebrospinal fluid barriers. The Journal of Pharmacology and Experimental Therapeutics. 336: 506-15. PMID 21057057 DOI: 10.1124/Jpet.110.172981 |
0.473 |
|
2010 |
Rodgers J. Trypanosomiasis and the brain Parasitology. 137: 1995-2006. PMID 20028610 DOI: 10.1017/S0031182009991806 |
0.511 |
|
2009 |
Rodgers J, Stone TW, Barrett MP, Bradley B, Kennedy PG. Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis. Brain : a Journal of Neurology. 132: 1259-67. PMID 19339256 DOI: 10.1093/Brain/Awp074 |
0.487 |
|
2009 |
Rodgers J. Human African trypanosomiasis, chemotherapy and CNS disease Journal of Neuroimmunology. 211: 16-22. PMID 19269696 DOI: 10.1016/J.Jneuroim.2009.02.007 |
0.456 |
|
2009 |
Sanderson L, Dogruel M, Rodgers J, De Koning HP, Thomas SA. Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein. The Journal of Pharmacology and Experimental Therapeutics. 329: 967-77. PMID 19261919 DOI: 10.1124/Jpet.108.149872 |
0.461 |
|
2008 |
Sanderson L, Dogruel M, Rodgers J, Bradley B, Thomas SA. The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain. Journal of Neurochemistry. 107: 1136-46. PMID 18823367 DOI: 10.1111/J.1471-4159.2008.05706.X |
0.507 |
|
2008 |
Jones A, Rodgers J, Bradley B, Kennedy P. Novel forms of oral melarsoprol cure CNS stage Trypanosoma brucei brucei infection in a murine model of human African trypanosomiasis Bmc Proceedings. 2. DOI: 10.1186/1753-6561-2-S1-P28 |
0.374 |
|
2007 |
Rodgers J, Bradley B, Kennedy PG. Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis. Parasitology International. 56: 321-4. PMID 17643344 DOI: 10.1016/J.Parint.2007.06.008 |
0.403 |
|
2005 |
Sternberg JM, Rodgers J, Bradley B, Maclean L, Murray M, Kennedy PG. Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology. Journal of Neuroimmunology. 167: 81-9. PMID 16054238 DOI: 10.1016/J.Jneuroim.2005.06.017 |
0.381 |
|
2004 |
Grab DJ, Nikolskaia O, Kim YV, Lonsdale-Eccles JD, Ito S, Hara T, Fukuma T, Nyarko E, Kim KJ, Stins MF, Delannoy MJ, Rodgers J, Kim KS. African trypanosome interactions with an in vitro model of the human blood-brain barrier. The Journal of Parasitology. 90: 970-9. PMID 15562595 DOI: 10.1645/Ge-287R |
0.43 |
|
2003 |
Kennedy PG, Rodgers J, Bradley B, Hunt SP, Gettinby G, Leeman SE, de Felipe C, Murray M. Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice. Brain : a Journal of Neurology. 126: 1683-90. PMID 12805119 DOI: 10.1093/Brain/Awg160 |
0.389 |
|
2002 |
Jennings FW, Rodgers J, Bradley B, Gettinby G, Kennedy PG, Murray M. Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen. Parasitology International. 51: 381-8. PMID 12421636 DOI: 10.1016/S1383-5769(02)00044-2 |
0.461 |
|
2001 |
Eckersall PD, Gow JW, McComb C, Bradley B, Rodgers J, Murray M, Kennedy PGE. Cytokines and the acute phase response in post-treatment reactive encephalopathy of Trypanosoma brucei brucei infected mice Parasitology International. 50: 15-26. PMID 11267928 DOI: 10.1016/S1383-5769(00)00065-9 |
0.372 |
|
1997 |
Kennedy PG, Rodgers J, Jennings FW, Murray M, Leeman SE, Burke JM. A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proceedings of the National Academy of Sciences of the United States of America. 94: 4167-70. PMID 9108123 DOI: 10.1073/Pnas.94.8.4167 |
0.365 |
|
1997 |
Jennings FW, Gichuki CW, Kennedy PGE, Rodgers J, Hunter CA, Murray M, Burke JM. The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis Neuropathology and Applied Neurobiology. 23: 225-234. DOI: 10.1111/J.1365-2990.1997.Tb01206.X |
0.416 |
|
Show low-probability matches. |